Targeting MKK3/c-Myc interaction to overcome osimertinib acquired resistance in EGFR mutant lung cancer is a research paper published in Cancer Letters (2025). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health National Cancer Institute
Grant: P01 CA257906
National Institutes of Health National Cancer Institute
Grant: R01 CA223220
National Institutes of Health National Cancer Institute
Grant: R01 CA284386
National Institutes of Health National Cancer Institute
Grant: UG1 CA233259
National Institutes of Health National Cancer Institute
Grant: P50 CA217691
NCI NIH HHS
Grant: R01 CA245386
National Institutes of Health
FWCI
2.24
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals